Mineralys Therapeutics Inc. (MLYS) NASDAQ
$14.47 -0.07 (-0.48%)
Market Cap: $591.20M
As of 06/01/23 04:00 PM EDT. Market closed.
Mineralys Therapeutics Inc. (MLYS)
NASDAQ
$14.47
-0.07 (-0.48%)
Market Cap: $591.20M
As of 06/01/23 04:00 PM EDT. Market closed.
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
12
URL
Address
.
PRICE CHART FOR MINERALYS THERAPEUTICS INC
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$14.54
Days Range
$13.80 - $15.08
52 week range
$12.62 - $21.98
Volume
99,689
Avg. Volume (30 days)
95,550
Market Cap
$591.20M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
40,856,653
Open
$0
Previous Close
$14.54
Days Range
$13.80 - $15.08
52 week range
$12.62 - $21.98
Volume
99,689
Avg. Volume (30 days)
95,550
Market Cap
$591.20M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
40,856,653
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MINERALYS THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Feb 14, 2023 | Buy | $16.00 | 312,500 | 5,000,000 | 3,218,106 | Feb 16, 2023, 09:00 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Feb 14, 2023 | Buy | $16.00 | 1,250,000 | 20,000,000 | 1,867,229 | Feb 16, 2023, 05:04 PM |
| Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | Feb 14, 2023 | Buy | $16.00 | 6,250 | 100,000 | 350,811 | Feb 16, 2023, 04:54 PM |
| AKKARAJU SRINIVAS | Director | Feb 14, 2023 | Buy | $16.00 | 937,500 | 15,000,000 | 4,519,361 | Feb 16, 2023, 04:54 PM |
| Slingsby Brian Taylor | Director | Feb 14, 2023 | Buy | $16.00 | 250,000 | 4,000,000 | 9,194,579 | Feb 16, 2023, 04:54 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 02/14/2023 | 5,000,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 02/14/2023 | 20,000,000 |
| Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | 02/14/2023 | 100,000 |
| AKKARAJU SRINIVAS | Director | 02/14/2023 | 15,000,000 |
| Slingsby Brian Taylor | Director | 02/14/2023 | 4,000,000 |
FUNDS WITH A POSITION IN MINERALYS THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 3,178,476 | 1.13% | New | Other |
| BLACKROCK INC. | 749,689 | 0.00035% | New | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 729,021 | 0.25% | New | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 453,001 | 0.1% | New | Growth |
| GEODE CAPITAL MANAGEMENT, LLC | 283,653 | 0.00058% | New | Other |
| PENTWATER CAPITAL MANAGEMENT LP | 70,000 | 0.01% | New | Event Driven |